
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
---|---|---|---|---|---|---|
09/30/2025 | Q3 | $47.4M | -- | -- | $1.47 | -- |
07/25/2025 | Q2 | $46.9M | -- | -- | $1.47 | -- |
05/01/2025 | Q1 | $44.3M | $45.1M | $1.49 | $1.33 | $0.17 |
02/06/2025 | Q4 | $45.6M | $44.2M | $0.61 | $1.51 | -$0.90 |
11/05/2024 | Q3 | $37M | $45M | -$0.43 | $1.08 | -$1.51 |
07/25/2024 | Q2 | $23.5M | $22.5M | $0.46 | $0.52 | -$0.06 |
04/30/2024 | Q1 | $23.5M | $22.7M | $0.49 | $0.65 | -$0.16 |
01/25/2024 | Q4 | $25.1M | $23.5M | $0.51 | $0.89 | -$0.38 |
10/30/2023 | Q3 | -- | -- | $0.95 | $0.93 | $0.02 |
07/25/2023 | Q2 | -- | -- | $1.31 | $1.06 | $0.25 |
04/27/2023 | Q1 | -- | -- | $1.05 | $1.02 | $0.03 |
01/26/2023 | Q4 | -- | -- | $1.27 | $1.39 | -$0.12 |
10/20/2022 | Q3 | -- | -- | $1.38 | $1.47 | -$0.09 |
07/21/2022 | Q2 | -- | -- | $1.30 | $1.30 | -- |
04/26/2022 | Q1 | -- | -- | $1.33 | $1.00 | $0.33 |
01/31/2022 | Q4 | -- | -- | $2.28 | -- | -- |
10/22/2021 | Q3 | -- | -- | $1.26 | -- | -- |
07/21/2021 | Q2 | -- | -- | $1.18 | -- | -- |
05/07/2021 | Q1 | -- | -- | $1.31 | -- | -- |
02/01/2021 | Q4 | -- | -- | $1.13 | -- | -- |
11/03/2020 | Q3 | -- | -- | $1.14 | -- | -- |
07/31/2020 | Q2 | -- | -- | $1.03 | -- | -- |
04/24/2020 | Q1 | -- | -- | $0.71 | -- | -- |
01/24/2020 | Q4 | -- | -- | $0.92 | -- | -- |
10/22/2019 | Q3 | -- | -- | $0.97 | -- | -- |
07/23/2019 | Q2 | -- | -- | $0.96 | -- | -- |
04/23/2019 | Q1 | -- | -- | $0.87 | -- | -- |
01/29/2019 | Q4 | -- | -- | $0.86 | -- | -- |
10/23/2018 | Q3 | -- | -- | $0.91 | -- | -- |
07/24/2018 | Q2 | -- | -- | $0.81 | -- | -- |
04/25/2018 | Q1 | -- | -- | $0.79 | -- | -- |
02/02/2018 | Q4 | -- | -- | $0.36 | -- | -- |
10/24/2017 | Q3 | -- | -- | $0.72 | -- | -- |
07/24/2017 | Q2 | -- | -- | $0.76 | -- | -- |
04/24/2017 | Q1 | -- | -- | $0.65 | -- | -- |
01/31/2017 | Q4 | -- | -- | $0.64 | -- | -- |
10/21/2016 | Q3 | -- | -- | $0.69 | -- | -- |
07/22/2016 | Q2 | -- | -- | $0.66 | -- | -- |
04/20/2016 | Q1 | -- | -- | $0.66 | -- | -- |
02/02/2016 | Q4 | -- | -- | $0.52 | -- | -- |
10/22/2015 | Q3 | -- | -- | $0.58 | -- | -- |
Peoples Financial Services reported $45.1M worth of top line sales in its most recent quarter.
Peoples Financial Services announced earnings per share of $1.49 which represents a beat of analyst forecast a $1.33 per share.
Peoples Financial Services reported -- that represents -- per share over the last quarter.
Peoples Financial Services's earnings are forecast to grow from $0.99 per share to $4.30 per share next year representing an increase of 497.48%.
Peoples Financial Services's next earnings date is July 25, 2025.
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.